References
- Klastersky J. Concept of empiric therapy with antibiotic combinations. Am J Med 1986; 80: 2–11, Suppl. 5C
- De Pauw BE, Kauw F, Muytjens H, Williams KJ, Bothof TH. Randomised study of ceftazidime versus gentamicin plus cefotaxime for infection in severe granulocytopenic patients. J Antimicrob Chemother 1983; 12: 93–99, Suppl. A
- Donnelly JP, Marcus RE, Goldman JM, Cohen J, Worsley AM, Catovsky D, Darrell JH, Want SV, Gallon DA. Ceftazidime as first-line therapy for fever in acute leukaemia. J Infect 1985; 11: 205–215
- Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin M, Skelton J, Thaler M, Wesley R. A randomised trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever neutropenia. N Engl J Med 1986; 315: 552–558
- Wade JC, Johnson DE, Bustamante CI. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients. Am J Med 1986; 80: 85–95, Suppl. 5C
- Meyer RD. Risk factors and comparison of clinical nephrotoxicity of aminoglycosides. Am J Med 1986; 80: 119–124, Suppl. 6B
- Gatell JM, Ferran F, Araujo V, Bonet M, Soriano E, Traserra J, SanMiguel JG. Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother 1987; 31: 1383–1387
- De Pauw BE, Williams K, De Neeff J, Bothof T, De Witte T, Holdrinet R, Haanen C. A randomised prospective study of ceftazidime versus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother 1985; 28: 824–828
- Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis; an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 97: 503–508
- Whimbey E, Kiehn TE, Bannon P, Blevins A, Armstrong D. Bacteremia and fungemia in patients with neoplastic disease. Am J Med 1987; 82: 723–730
- National Committee for Clinical Laboratory Standards 194 (Approved standard M2-A3). Performance standards for antimicrobic disk susceptibility tests. National Committee for Clinical Laboratory Standards, Villanova, Pa 1984
- The EORTC International Antimicrobic Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692–1698
- Bodey GP. Infection in cancer patients: a continuing association. Am J Med 81. Suppl. 1986; 1A: 11–26
- Neftel KA, Mauser SP, Muller MR. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis 1985; 152(98)
- Stover DE, Zaman MB, Hajdu SI, Lange M, Gold J, Armstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med 1984; 101: 1–7
- Winston DJ, Young LS, Hewitt WL, Gale RP. Piperacillin plus amikacin therapy vs. carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. Arch Intern Med 1982; 142: 1663–1667